Cargando…

Laboratory Cost Analysis of Conventional and Newer Molecular Tests for Diagnosis of Presumptive Multidrug-Resistant Tuberculosis Patients

INTRODUCTION: Tuberculosis (TB) remains a deadliest infectious disease. Lack of rapid test with low cost is one of the important challenges to eradicate the TB. The objective of the study was to analyze the laboratory costs of conventional and newer molecular tests, for diagnosis of presumptive mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Raj Narayan, Verma, Ajoy Kumar, Kaushik, Gaurav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552341/ https://www.ncbi.nlm.nih.gov/pubmed/36237568 http://dx.doi.org/10.4103/jgid.jgid_309_21

Ejemplares similares

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
por: Verma, Ajoy Kumar, et al.
Publicado: (2022)

Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia
por: Khann, Sokhan, et al.
Publicado: (2013)

Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis
por: Pandey, Pratikshya, et al.
Publicado: (2017)

Presumptive tests.
por: Flamm, W G
Publicado: (1978)

Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
por: Steffen, Ricardo E., et al.
Publicado: (2020)

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017
por: Rathi, Priya, et al.
Publicado: (2020)

Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China
por: Pang, Yu, et al.
Publicado: (2013)

Alzheimer's disease: Newer biomarkers
por: Dangi, Ankit, et al.
Publicado: (2021)

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa
por: Shah, Maunank, et al.
Publicado: (2013)

Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia
por: Sinshaw, Waganeh, et al.
Publicado: (2019)

Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
por: Gomathi, N.S., et al.
Publicado: (2020)

Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States
por: Cowan, James F., et al.
Publicado: (2017)

Examination of respiratory specimens improves microbiological diagnosis of patients with presumptive extrapulmonary tuberculosis
por: Spener-Gomes, Renata, et al.
Publicado: (2021)

Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda
por: Batwala, Vincent, et al.
Publicado: (2011)

Newer laboratory approaches for assessing visual dysfunction.
por: Shinkman, P G, et al.
Publicado: (1982)

Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan
por: Huang, Wei-Chang, et al.
Publicado: (2022)

The value of laboratory tests in the diagnosis of tuberculosis
por: PETRE, NICOLAE, et al.
Publicado: (2017)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients
por: Darma, Surya, et al.
Publicado: (2020)

CAR T cell therapy: newer approaches to counter resistance and cost
por: Yadav, Rajesh Kumar, et al.
Publicado: (2020)

Challenges in Laboratory Diagnosis of Malaria in a Low-Resource Country at Tertiary Care in Eastern Nepal: A Comparative Study of Conventional vs. Molecular Methodologies
por: Dahal, Pragyan, et al.
Publicado: (2021)

Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever
por: D'Acremont, Valérie, et al.
Publicado: (2009)

Pathways and associated costs of care in patients with confirmed and presumptive tuberculosis in Tanzania: A cross-sectional study
por: Mhalu, Grace, et al.
Publicado: (2019)

Are the Newer Carbapenems of Any Value against Tuberculosis
por: Gonzalo, Ximena, et al.
Publicado: (2022)

Loss to follow up during diagnosis of presumptive pulmonary tuberculosis at a tertiary care hospital
por: Pala, Star, et al.
Publicado: (2018)

The place of presumptive diagnosis in the management of peritoneal tuberculosis: A case report from rural Togo
por: Essobiyou, Tamassi Bertrand, et al.
Publicado: (2023)

Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis
por: Diniz, João Luiz Cioglia Pereira, et al.
Publicado: (2015)

Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis
por: Muyoyeta, Monde, et al.
Publicado: (2017)

Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo
por: Yotebieng, Marcel, et al.
Publicado: (2016)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Clinical and laboratory profile of patients with presumptive clinical diagnosis of acute bacterial meningitis and its short-term complications
por: Garg, Anubha, et al.
Publicado: (2022)

Molecular Detection of Mycobacterium tuberculosis in Oral Mucosa from Patients with Presumptive Tuberculosis
por: Molina-Moya, Barbara, et al.
Publicado: (2020)

Clinical and radiographic characteristics of presumptive tuberculosis patients previously treated for tuberculosis in Zambia
por: Mateyo, Kondwelani, et al.
Publicado: (2022)

Comparison of Conventional versus Molecular Semi-Quantitative Assay in Presumptive Pulmonary Tuberculosis Cases: A Study from Eastern India
por: Purohit, Geetarani, et al.
Publicado: (2020)

Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016)

Presumptive ocular tuberculosis: A case series of rare cases
por: Singh, Arti, et al.
Publicado: (2023)

Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
por: Maharjan, Elina, et al.
Publicado: (2017)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Predominance of Other Pathogenic Bacteria among Presumptive Tuberculosis Cases Attending Tuberculosis Clinics in Mwanza, Tanzania: A Cross-Sectional Laboratory-Based Study
por: Buchera, Florencia S., et al.
Publicado: (2022)

On the Presumption of Survivorship
por: Pettigrew, James Bell
Publicado: (1865)

Cannot write session to /tmp/vufind_sessions/sess_60aj4rp32ap138s5et92btft7b